Recent

% | $
Quotes you view appear here for quick access.

ChromaDex Corporation Message Board

  • financesajeed financesajeed Mar 10, 2013 12:57 PM Flag

    Likely effect of acquisition of Spherix Consulting by CDXC ChromaDex (CDXC),

    ChromaDex (CDXC), an innovative natural product company which provides proprietary, science based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic, and pharmaceuticals industry. Recently, the company has bought all shares of Spherix Consulting, Inc, a subsidiary company of Spherix Incorporated (SPEX). This initiative was as part of CDXC’s business expansionary mission and vision. Resulting the above business acquire transaction, Spherix Consulting became a wholly owned subsidiary of CDEX. Spherix Consulting has a well-established list of Fortune 1000 customers, as the company has good presence in scientific and regulatory consulting. The above business acquire is considered to effect as an immediate increase in revenue of ChromaDex, as expected by the company management. According to Frank Jaksch, CEO and co-Founder of ChromaDex, "Spherix Consulting is a premier provider of product regulatory approval and scientific advisory services. Given the rapidly changing regulatory environment, these services have never been more critical for suppliers, manufacturers and retailers. By acquiring Spherix Consulting we provide this valuable expertise to better support our customers' product development outcomes." As stated in the press release, Spherix Consulting provides its clients in the food, supplement and pharmaceutical industries with effective solutions to manage potential health and regulatory risks. Its science-based solutions are for both new and existing products that may be subject to product liability and/or exposed to changing scientific standards or public perceptions; literature evaluations; and design and assessment of pre-clinical and clinical safety testing. Spherix Consulting specializes in regulatory submissions for food and dietary supplement ingredients (GRAS, NDIN, Food Additive Petitions, Novel Food Petitions). For its clients involved in drug development within the pharmaceutical industry, Spherix provides

 
CDXC
3.77-0.05(-1.31%)Aug 24 4:00 PMEDT